Telum Therapeutics

Provider of the drug for treating multi-drug resistance bacterial infection

placeNoain, Navarre, Spain calendar_todayFounded 2019 groups17 employees language telumtherapeutics.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace slowing. Cited 113 times.

YearFilings
20211
20221
20231

Social engagement

Social engagement: 2.1K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Invivo Ventures, Clave, CDTI.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%

Recent activity

4 Mar 2026
Event
AMR Conference
6 Nov 2025
Recognition
3 Oct 2025
Milestone
regulatory
Coming soon